Our Team
Stephen Smith, Ph.D.
Dr. Stephen Smith is the inventor of QMI and a principal investigator at the Norcliffe Foundation Center for Integrative Brain Research at Seattle Children’s. He also serves as an assistant professor at the University of Washington School of Medicine. Trained at Caltech under Dr. Paul Patterson and supported by Autism Speaks, Dr. Smith completed postdoctoral fellowships at Harvard Medical School and the Mayo Clinic. His lab pioneered the development of Quantitative Multiplex Immunoprecipitation (QMI), a proteomic platform that maps dynamic protein signaling networks in T cells. Backed by a K99/R00 award from the National Institute of Mental Health, his research bridges immunology and systems neuroscience, enabling predictive diagnostics and rational design of next-generation cell therapies.
Cameron McCann
Biotech entrepreneur driving strategy, partnerships, and fundraising to scale QMI as a leader in CAR-T optimization. Cameron brings prior experience at venture-backed startups and holds degrees in Entrepreneurship and Psychology from the University of Washington. With a background in R&D at the forefront of treatments for mental health and neurological disorders, he is deeply passionate about improving patient outcomes through better translational tools. His work centers on making CAR-T development more predictive, scalable, and clinically successful by leveraging QMI to decode protein signaling networks.